63 related articles for article (PubMed ID: 8682182)
1. Neuroprotective effects of the pyrrolopyrimidine U-104067F in 3-acetylpyridine-treated rats.
Sethy VH; Wu H; Oostveen JA; Hall ED
Exp Neurol; 1996 Jul; 140(1):79-83. PubMed ID: 8682182
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effects of the GABA(A) receptor partial agonist U-101017 in 3-acetylpyridine-treated rats.
Sethy VH; Wu H; Oostveen JA; Hall ED
Neurosci Lett; 1997 May; 228(1):45-9. PubMed ID: 9197284
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of the dopamine agonists pramipexole and bromocriptine in 3-acetylpyridine-treated rats.
Sethy VH; Wu H; Oostveen JA; Hall ED
Brain Res; 1997 Apr; 754(1-2):181-6. PubMed ID: 9134974
[TBL] [Abstract][Full Text] [Related]
4. Two novel pyrrolopyrimidine lipid peroxidation inhibitors U-101033E and U-104067F protect facial motor neurons following neonatal axotomy.
Smith SL; Oostveen JA; Hall ED
Exp Neurol; 1996 Oct; 141(2):304-9. PubMed ID: 8812165
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of the novel brain-penetrating pyrrolopyrimidine antioxidants U-101033E and U-104067F against post-ischemic degeneration of nigrostriatal neurons.
Andrus PK; Fleck TJ; Oostveen JA; Hall ED
J Neurosci Res; 1997 Mar; 47(6):650-4. PubMed ID: 9089214
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective efficacy and mechanisms of novel pyrrolopyrimidine lipid peroxidation inhibitors in the gerbil forebrain ischemia model.
Oostveen JA; Dunn E; Carter DB; Hall ED
J Cereb Blood Flow Metab; 1998 May; 18(5):539-47. PubMed ID: 9591846
[TBL] [Abstract][Full Text] [Related]
7. Activity-induced elevation of cerebellar cyclic GMP occurs in the absence of climbing fiber pathways.
McCaslin PP; Morgan WW
Brain Res; 1987 Jun; 414(2):381-4. PubMed ID: 3040168
[TBL] [Abstract][Full Text] [Related]
8. Correlations between cerebellar cyclic GMP and motor effects induced by deltamethrin: independence of olivo-cerebellar tract.
Brodie ME
Neurotoxicology; 1983; 4(4):1-11. PubMed ID: 6322058
[TBL] [Abstract][Full Text] [Related]
9. Endogenous estrogen formation is neuroprotective in model of cerebellar ataxia.
Sierra A; Azcoitia I; Garcia-Segura L
Endocrine; 2003 Jun; 21(1):43-51. PubMed ID: 12777702
[TBL] [Abstract][Full Text] [Related]
10. Hericium erinaceus potentially rescues behavioural motor deficits through ERK-CREB-PSD95 neuroprotective mechanisms in rat model of 3-acetylpyridine-induced cerebellar ataxia.
Chong PS; Khairuddin S; Tse ACK; Hiew LF; Lau CL; Tipoe GL; Fung ML; Wong KH; Lim LW
Sci Rep; 2020 Sep; 10(1):14945. PubMed ID: 32913245
[TBL] [Abstract][Full Text] [Related]
11. 3-Acetylpyridine produces age-dependent excitotoxic lesions in rat striatum.
Schulz JB; Henshaw DR; Jenkins BG; Ferrante RJ; Kowall NW; Rosen BR; Beal MF
J Cereb Blood Flow Metab; 1994 Nov; 14(6):1024-9. PubMed ID: 7929644
[TBL] [Abstract][Full Text] [Related]
12. Cerebellar output regulation by the climbing and mossy fibers with and without the inferior olive.
Bardin JM; Batini C; Billard JM; Buisseret-Delmas C; Conrath-Verrier M; Corvaja N
J Comp Neurol; 1983 Feb; 213(4):464-77. PubMed ID: 6300201
[TBL] [Abstract][Full Text] [Related]
13. Co-treatment with riluzole, a neuroprotective drug, ameliorates the 3-acetylpyridine-induced neurotoxicity in cerebellar Purkinje neurones of rats: behavioural and electrophysiological evidence.
Janahmadi M; Goudarzi I; Kaffashian MR; Behzadi G; Fathollahi Y; Hajizadeh S
Neurotoxicology; 2009 May; 30(3):393-402. PubMed ID: 19442824
[TBL] [Abstract][Full Text] [Related]
14. Amelioration of mitochondrial function by a novel antioxidant U-101033E following traumatic brain injury in rats.
Xiong Y; Peterson PL; Muizelaar JP; Lee CP
J Neurotrauma; 1997 Dec; 14(12):907-17. PubMed ID: 9475372
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologically induced changes in the 3':5'-cyclic guanosine monophosphate content of rat cerebellar cortex: difference between apomorphine, haloperidol and harmaline.
Biggio G; Costa E; Guidotti A
J Pharmacol Exp Ther; 1977 Jan; 200(1):207-15. PubMed ID: 13199
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of trans-crotononitrile and 3-acetylpyridine on inferior olive integrity and behavioural performance in the rat.
Seoane A; Apps R; Balbuena E; Herrero L; Llorens J
Eur J Neurosci; 2005 Aug; 22(4):880-94. PubMed ID: 16115211
[TBL] [Abstract][Full Text] [Related]
17. [The neuroprotective effect of the glutamate antagonist acamprosate following experimental cerebral ischemia. A study with the lipid peroxidase inhibitor u-101033e].
Engelhard K; Werner C; Lu H; Möllenberg O; Zieglgänsberger W; Kochs E
Anaesthesist; 2000 Sep; 49(9):816-21. PubMed ID: 11076270
[TBL] [Abstract][Full Text] [Related]
18. 3-Acetylpyridine neurotoxicity in mice.
Wecker L; Marrero-Rosado B; Engberg ME; Johns BE; Philpot RM
Neurotoxicology; 2017 Jan; 58():143-152. PubMed ID: 27986589
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial dysfunction after experimental traumatic brain injury: combined efficacy of SNX-111 and U-101033E.
Xiong Y; Peterson PL; Verweij BH; Vinas FC; Muizelaar JP; Lee CP
J Neurotrauma; 1998 Jul; 15(7):531-44. PubMed ID: 9674556
[TBL] [Abstract][Full Text] [Related]
20. Cerebellar cyclic GMP in p,p'-DDT myoclonus: effects of antimyoclonic agents.
Chung E
Res Commun Chem Pathol Pharmacol; 1983 Apr; 40(1):87-98. PubMed ID: 6306746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
